| Literature DB >> 19657463 |
Rajan Saini1, Jacinta Santhanam, Nor Hayati Othman, Deepti Saini, Thean-Hock Tang.
Abstract
There is a growing appreciation of the potential value for routine screening for the presence of HPV not only for cervical specimens but also from oral cavity. The purpose of this study was to develop and clinically evaluate a single-tube seminested PCR assay for the detection of HPV. Several parameters such as PCR primers, primer annealing temperature, the number of PCR cycles and concentration of PCR components were optimized. The assay was evaluated using HPV inserts of type 6, 11, 16, 18, 31, 33, 38 and 51. Evaluation of seminested PCR assay was performed with cervical scrapings from 30 patients and buccal swabs from 30 head and neck cancer patients and results were compared with those of two-tube nested PCR. The results were found to be comparable with a total of 60% (36/60) of samples being positive for HPV using the single-tube assay, while 62% (37/60) positivity was found with two-tube PCR assay. We succeeded in developing a single-tube seminested PCR method for HPV DNA detection which is easier than the conventional nested PCR and can be further evaluated as a potential screening tool for detecting HPV in oral and cervical regions.Entities:
Year: 2009 PMID: 19657463 PMCID: PMC2720518 DOI: 10.2174/1874285800903010106
Source DB: PubMed Journal: Open Microbiol J ISSN: 1874-2858
Detection of HPV in the Cervical Scrapings of Clinically Suspected Patients by Two-Tube Nested and Single-Tube Seminested PCR
| Case no. | Diagnosis | Age | Two-Tube Nested PCR | Single-Tube Seminested PCR |
|---|---|---|---|---|
| 1 | Normal | 36 | - | - |
| 2 | CIN1 | 54 | + | + |
| 3 | Normal | 60 | + | + |
| 4 | Normal | 31 | + | + |
| 5 | CIN1 | 48 | + | + |
| 6 | Normal | 40 | - | - |
| 7 | STD | 42 | + | + |
| 8 | CIN1 | 62 | + | + |
| 9 | Normal | 39 | - | - |
| 10 | Normal | 51 | + | + |
| 11 | Normal | 42 | - | - |
| 12 | CIN1 | 39 | + | + |
| 13 | CIN1 | 62 | + | + |
| 14 | STD | 36 | + | + |
| 15 | STD | 41 | + | + |
| 16 | Normal | 41 | - | - |
| 17 | Normal | 46 | + | + |
| 18 | Normal | 48 | + | + |
| 19 | CIN1 | 57 | - | - |
| 20 | Normal | 50 | + | + |
| 21 | CIN2 | 64 | + | + |
| 22 | Normal | 58 | - | - |
| 23 | Normal | 61 | - | - |
| 24 | STD | 40 | + | + |
| 25 | CIN1 | 46 | + | + |
| 26 | Normal | 35 | - | - |
| 27 | STD | 38 | + | + |
| 28 | Normal | 49 | - | - |
| 29 | CIN2 | 53 | - | + |
| 30 | Normal | 41 | - | - |
CIN 1=Cervical Intraepithelial Neoplasia Grade I; CIN2=Cervical Intraepithelial Neoplasia Grade II; STD=Sexually transmitted disease; +=positive; -=negative.
Detection of HPV in the Buccal Swabs of Head and Neck Cancer Patients by Two-Tube Nested and Single-Tube Seminested PCR
| Case no. | Diagnosis | Stage | Age | Sex | Two-Tube Nested | Single-Tube Seminested |
|---|---|---|---|---|---|---|
| 1 | Laryngeal cancer | IV | 69 | F | - | - |
| 2 | Nasopharyngeal cancer | IV | 33 | M | + | - |
| 3 | Oral cancer | II | 47 | M | - | - |
| 4 | Tonsillar cancer | IV | 73 | F | + | + |
| 5 | Oral cancer | IV | 53 | M | - | - |
| 6 | Nasopharyngeal cancer | IV | 59 | M | + | + |
| 7 | Oral cancer | III | 53 | M | + | + |
| 8 | Nasopharyngeal cancer | I | 51 | F | - | - |
| 9 | Parotid Gland cancer | NA | 59 | F | - | - |
| 10 | Laryngeal cancer | IV | 73 | M | + | + |
| 11 | Nasopharyngeal cancer | IV | 53 | F | + | - |
| 12 | Nasopharyngeal cancer | IV | 28 | F | + | + |
| 13 | Nasopharyngeal cancer | IV | 50 | F | + | + |
| 14 | Nasopharyngeal cancer | IV | 55 | F | + | + |
| 15 | Nasopharyngeal cancer | IV | 57 | M | + | + |
| 16 | Nasopharyngeal cancer | IV | 67 | M | - | - |
| 17 | Nasopharyngeal cancer | IV | 19 | M | + | + |
| 18 | Nasopharyngeal cancer | IV | 58 | M | - | - |
| 19 | Oral cancer | II | 71 | M | + | + |
| 20 | Nasopharyngeal Cancer | IV | 71 | M | - | - |
| 21 | Nasopharyngeal cancer | IV | 47 | M | + | + |
| 22 | Laryngeal cancer | I | 39 | F | - | - |
| 23 | Nasopharyngeal cancer | IV | 60 | M | - | - |
| 24 | Oral cancer | IV | 69 | F | + | + |
| 25 | Nasopharyngeal cancer | IV | 30 | M | + | + |
| 26 | Tonsillar cancer | IV | 58 | F | + | + |
| 27 | Oropharyngeal cancer | IV | 75 | M | + | + |
| 28 | Nasopharyngeal cancer | IV | 32 | M | + | + |
| 29 | Sinonasal cancer | NA | 65 | F | + | + |
| 30 | Sinonasal cancer | NA | 53 | - | - |
+= positive; -= negative. NA = not available.